Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This comparison draws on peer-reviewed clinical data, FDA documentation, and the latest Phase 3 trial results to give you the most complete, evidence-based picture available
You can read more about tirzepatide and its impressive results in other clinical trials in our article: Tirzepatide Dramatically Lowers Weight and A1C. Heart disease is a serious problem for people with type 2 diabetes
A new study, the STEP trial, examined semaglutides impact on cardiovascular outcomes in overweight people or people with obesity and established cardiovascular disease
In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51
US$ 26.16
US$ 28.65
US$ 21.44
US$ 24.31
US$ 28.26
